Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke

International Journal of Stroke

Volumn 5, Issue 1, 2010, Pages 4-9

  Bonvini, R F ^a   Sztajzel, R ^a   Dorsaz, P A ^a   Righini, M ^a   Bonvin, C ^a   Alibegovic, J ^a   Sigwart, U ^a   Camenzind, E ^a   Verin, V ^a   Sztajzel, J ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

7 day event loop recording; ASD; Atrial fibrillation; Closure device; Percutaneous closure; PFO

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DILTIAZEM; FLECAINIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; PATENT FORAMEN OVALE; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIAC SURGICAL PROCEDURES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 73949141054     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00336.x     Document Type: Article

References (23)

1. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-9.
2. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003, 139:753-60.
3. Windecker S, Wahl A, Nedeltchev K. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004, 44:750-8.
4. Martin F, Sanchez PL, Doherty E. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002, 106:1121-6.
5. Bruch L, Parsi A, Grad MO. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation 2002, 105:2845-8.
6. Windecker S, Wahl A, Chatterjee T. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 2000, 101:893-8.
7. Krumsdorf U, Ostermayer S, Billinger K. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004, 43:302-9.
8. Van Camp G, Schulze D, Cosyns B, Vandenbossche JL. Relation between patent foramen ovale and unexplained stroke. Am J Cardiol 1993, 71:596-8.
9. De Belder MA, Tourikis L, Leech G, Camm AJ. Risk of patent foramen ovale for thromboembolic events in all age groups. Am J Cardiol 1992, 69:1316-20.
10. Brandt RR, Neumann T, Neuzner J. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr 2002, 15:1094-8.
11. Jabaudon D, Sztajzel J, Sievert K. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 2004, 35:1647-51.
12. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001, 38:613-23.
13. Alibegovic J, Bonvini R, Sigwart U, Dorsaz P, Camenzind E, Verin V. The role of the sizing balloon in selection of the patent foramen ovale closure device size. Exp Clin Cardol 2008, 13:42-6.
14. Christen T, Mach F, Didier D, Kalangos A, Verin V, Trindade PT. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr 2005, 6:465-9.
15. Egred M, Andron A, Albouanini K. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up. J Interven Cardiol 2007, 20:395-401.
16. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really " shut the door?" A prospective study with transcranial Doppler. Stroke 2004, 21:2140-4.
17. Burow A, Schwerzmann M, Wallmann D. Atrial fibrillation following transcatheter closure of patent foramen ovale in patients with stroke. Cardiology 2008, 111:47-50.
18. Berthet K, Lavergne T, Cohen A. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000, 31:398-403.
19. Rouesnel P, Babuty D, Fauchier L. Comparative study of atrial vulnerability in patients with unexplained ischemic stroke or lone atrial paroxysmal fibrillation. Ann Cardiol Angeiol (Paris) 2003, 52:220-5.
20. Alaeddini J, Feghali G, Jenkins S. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol 2006, 18:365-8.
21. Yasaka M, Otsubo R, Oe H, Minematsu K. Is stroke a paradoxical embolism in patients with patent foramen ovale? Intern Med 2005, 44:434-8.
22. Djaiani G, Phillips-Bute B, Podgoreanu M. The association of patent foramen ovale and atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg 2004, 98:585-9.
23. Barthélémy JC, Féasson-Gérard S, Garnier P. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003, 8:194-9.